Intellectus Partners’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Sell
74,633
-1,330
-2% -$35.7K 0.45% 52
2026
Q1
$1.58M Buy
75,963
+3,853
+5% +$91K 0.32% 81
2025
Q4
$2.34M Buy
72,110
+3,699
+5% +$158K 0.45% 58
2025
Q3
$3.88M Buy
68,411
+7,375
+12% +$378K 0.75% 26
2025
Q2
$3.04M Buy
+61,036
New +$2.76M 0.66% 34
2022
Q2
Sell
-10,200
Closed -$54K 261
2022
Q1
$54K Buy
+10,200
New +$50.5K 0.02% 230

Other funds holding HIMS

Intellectus Partners's HIMS Position: Q2 2026 in Review

Intellectus Partners reduced its Hims & Hers Health (HIMS) stake by 1.8% in Q2 2026, selling an estimated $35.7K and leaving 74,633 shares worth $2.59M. The position accounts for 0.45% of the portfolio, ranked #52.

Intellectus Partners first reported a position in HIMS in Q1 2022 and has held it in 6 quarters since. The position peaked at $3.88M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Intellectus Partners held 74,633 shares of Hims & Hers Health worth $2.59M as of Q2 2026.
  • Intellectus Partners sold 1,330 Hims & Hers Health shares in Q2 2026, an estimated $35.7K.
  • Hims & Hers Health made up 0.45% of Intellectus Partners's portfolio in Q2 2026, its #52 holding.
  • Intellectus Partners first reported a position in Hims & Hers Health in Q1 2022 and has held it in 6 quarters since.
  • Intellectus Partners's Hims & Hers Health position peaked at $3.88M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.